載入...
ICIs治疗晚期非小细胞肺癌免疫相关不良事件的系统综述及Meta分析
BACKGROUND AND OBJECTIVE: In recent years, immune checkpoint inhibitors (ICIs) have become a hot spot in cancer because of their remarkable survival benefits on non-small cell lung cancer (NSCLC) patients. However, the immune-related adverse events (ir-AEs) induced by ICIs have been frequently repor...
Na minha lista:
| 發表在: | Zhongguo Fei Ai Za Zhi |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
中国肺癌杂志编辑部
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519956/ https://ncbi.nlm.nih.gov/pubmed/32752580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2020.104.07 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|